¾ÅÐãÖ±²¥ Vice-Principal ResearchCompass North
Cntrl+ Inc. receives clearance from the US Food and Drug Administration
Apr 03, 2025
After an arduous journey, Cornwall-based Cntrl+ Inc. officially received clearance from the United States Food and Drug Administration (US FDA) for its reusable female bladder support in December 2024.
Compass North participant Fictionary lands investment opportunity
Dec 07, 2022
Kristina Stanley is the founder of Fictionary, a technology company that develops software which helps writers visualize their story arc by analyzing key story elements with AI and gauging how their manuscript compares to fundamental storytelling.
Queen’s Professor Stephen Archer's technology has multiple treatment applications
Nov 08, 2022
Professor Stephen Archer and his colleagues, Dr. Danchen Wu and Dr. Michael Wells, have developed an enzyme inhibitor and early research suggests that it may be very effective in fighting cancer, Alzheimer’s disease, pulmonary hypertension.
Building Momentum: How One WE-CAN Client Saw 3X Business Growth During a Global Pandemic
Sep 29, 2021
WE-CAN client Lisa Henderson M.A.A.T.O., CBCO is the President and Lead Designer at House of Three in Inverary, Ontario.
